Bisoprolol Fumarate
47 NDCs across 13 manufacturers|47 Generic,0 Brand
Bisoprolol Fumarate is used to treat angina pectoris, heart failure, hypertension, myocardial infarction and supraventricular tachycardia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 31, 1992, and the first generic was approved Nov 16, 2000. FDA's Orange Book lists 22 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $30 million on Bisoprolol Fumarate across 1.1 million claims for 286,000 beneficiaries.
Bisoprolol Fumarate is available as 47 NDCs from 13 manufacturers (47 generic, 0 brand), with NADAC prices from $0.11 to $2.52 per EA — the most expensive product costs about 22× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
47
47G / 0B
Manufacturers
13
competing in market
Price Spread
$0.11 – $2.52
per EA
7d Activity
avg -8.6% WoW · of 47 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
TruPharma LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta-Adrenergic Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
13 manufacturers producing BISOPROLOL FUMARATE(4 pricing outliers)
Frequently Asked Questions
What is Bisoprolol Fumarate used to treat?
Bisoprolol Fumarate is used to treat angina pectoris, heart failure, hypertension, myocardial infarction and supraventricular tachycardia, per the National Library of Medicine's MED-RT classification.
When did Bisoprolol Fumarate become available as a generic?
FDA approved the first generic Bisoprolol Fumarate (ANDA) on Nov 16, 2000. The Orange Book currently lists 22 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Bisoprolol Fumarate?
In 2024, Medicare Part D spent $30 million on Bisoprolol Fumarate across 1.1 million claims for 286,000 beneficiaries.
How many Bisoprolol Fumarate products are on the market?
The Bisoprolol Fumarate drug market contains 47 NDCs from 13 manufacturers — 47 generic and 0 brand products.
What is the price range for Bisoprolol Fumarate?
NADAC reference prices for Bisoprolol Fumarate range from $0.1142 to $2.5200 per EA — the most expensive product costs about 22× the cheapest.
Which manufacturers make Bisoprolol Fumarate?
13 manufacturers list Bisoprolol Fumarate in NADAC. Ranked by number of NDCs, the largest are TruPharma LLC (5), Aurobindo Pharma Limited (4), Unichem Pharmaceuticals (USA) Inc. (4), Sun Pharmaceutical Industries Inc. (4), NorthStar Rx LLC (4).
How has the price of Bisoprolol Fumarate changed recently?
Over the past 7 days, 0 Bisoprolol Fumarate NDCs rose and 45 fell, with a market-wide average change of -8.6%.